Cross-linked polymer modified nanoparticles
US11305024B2 · kind B2 · utility
0Cited by
2References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 10, 2021 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Aug 10, 2041 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y30/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are nanoconstructs comprising a nanoparticle, coated with additional agents such as cationic polymers, stabilizers, targeting molecules, labels, oligonucleotides and small molecules. These constructs may be used to deliver compounds to treat solid tumors and to diagnose cancer and other diseases. Further disclosed are methods of making such compounds and use of such compounds to treat or diagnose human disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.